Brand Name
Zunveyl
Generic Name
Benzgalantamine
View Brand Information FDA approval date: August 09, 2024
Form: Tablet
What is Zunveyl (Benzgalantamine)?
ZUNVEYL is indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults. ZUNVEYL is a cholinesterase inhibitor indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment